Connor, Clark & Lunn Investment Management »

Olema Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Olema Pharmaceuticals (OLMA) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Olema Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Olema Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Olema Pharmaceuticals by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 71k 14.91
2024-06-30 $305k 28k 10.82
2024-03-31 $588k 52k 11.32

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Agnico (AEM)
Toronto Dominion Bk Ont Com New (TD)
Suncor Energy (SU)
Enbridge (ENB)
NVIDIA Corporation (NVDA)
Cibc Cad (CM)
Tc Energy Corp (TRP)
Apple (AAPL)
Shopify Cl A Sub Vtg Shs (SHOP)
Bk Nova Cad (BNS)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Canadian Pacific Kansas City (CP)
Microsoft Corporation (MSFT)
Amazon (AMZN)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Olema Pharmaceuticals

FMR
Paradigm Biocapital Advisors
Bain Capital Life Sciences Investors
Henderson Group
BlackRock
BVF
Siren
Cormorant Asset Management
State Street Corporation
Vanguard Group
Logos Global Management
Vanguard Capital Management
RA Capital Management
Jennison Associates
Polar Capital Holdings

View all funds holding Olema Pharmaceuticals